Fresenius Medical Care AG & Co. KGaA (FMS) Stock Overview
Explore Fresenius Medical Care AG & Co. KGaA’s financial performance, market position, analyst ratings, and future outlook.
Fresenius Medical Care AG & Co. KGaA (FMS)
Key Financials
Key Financials
Market Cap
12B
P/E Ratio
11.26
EPS (TTM)
$1.90
ROE
0.07%
FMS Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Fresenius Medical Care AG & Co. KGaA (FMS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 49.85, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $25.73.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 11.26 and a market capitalization of 12B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.